GBP/USD 1.365 EUR/GBP 0.861 GBP/JPY 197.953 EUR/USD 1.175 GBP/AUD 2.077 USD/JPY 145.070 USD/CAD 1.357 AUD/USD 0.657 CAD/JPY 106.942 EUR/CAD 1.594 GBP/CAD 1.851 AUD/CAD 0.891 AUD/JPY 95.315 AUD/NZD 1.083 EUR/AUD 1.789 GBP/USD 1.365 EUR/GBP 0.861 GBP/JPY 197.953 EUR/USD 1.175 GBP/AUD 2.077 USD/JPY 145.070 USD/CAD 1.357 AUD/USD 0.657 CAD/JPY 106.942 EUR/CAD 1.594 GBP/CAD 1.851 AUD/CAD 0.891 AUD/JPY 95.315 AUD/NZD 1.083 EUR/AUD 1.789
CURRENCY .wiki

Finance News – Drugmakers

What is your interest today?

CNBC Business • Jun 17, 2025

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting close...

Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving significant market growth through...

Read Full Article →
The Guardian – Business • May 12, 2025

Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%’

The announcement of aggressive measures to lower medication costs in the United States has caused a notable decline in the market value of companies producing pharmaceuticals.

Read Full Article →
City A.M. • May 07, 2025

FTSE 100’s record run fades as pharma stocks slide on new Trump appointment 

The decline in major pharmaceutical shares contributed to a modest drop in the FTSE 100, signaling potential market uncertainty linked to changes in US regulatory leadership.

Read Full Article →
The Guardian – Business • May 05, 2025

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Imposing tariffs on pharmaceutical imports could disrupt supply chains and increase medication costs, potentially making essential treatments less accessible for many individuals a...

Read Full Article →
CNBC Business • May 01, 2025

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...

Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...

Read Full Article →